Table 4. Association between markers and pCR in the population of ER-positive, HER2-negative breast cancers.

Variable	AUC	IC 95%
Tumor size	0.58	(0.37 – 0.78)
Histological grade	0.88	(0.83 – 0.93)
Progesterone receptor	0.78	(0.72 – 0.83)
Mutated P53	0.72	(0.50 – 0.90)
Ki 67 (IHC)	0.63	(0.40 – 0.83)
Ki 67 (Rt-qPCR)	0.63	(0.42 – 0.85)
CDC2	0.56	(0.30 – 0.81)
CDC20	0.62	(0.37 – 0.84)
KPNA2	0.68	(0.47 – 0.87)
MYBL2	0.47	(0.22 – 0.72)
GGI	0.61	(0.35 – 0.85)
SUV max tumoral PET1	0.62	(0.36 – 0.85)
SUV max tumoral PET2	0.61	(0.35 – 0.86)
Delta SUV max tumoral (%)	0.83	(0.63 – 0.97)

^*95%CI = 95% confidence interval estimated using bootstrap.

AUC estimates with 95%CI excluding 0.50 are indicated in bold.